{"id":76772,"date":"2026-01-27T00:03:53","date_gmt":"2026-01-27T00:03:53","guid":{"rendered":"https:\/\/english.saigonbiz.com\/vn\/crinetics-pharmaceuticals-to-report-fourth-quarter-and-full-year-2025-financial-results-on-february-26-2026\/"},"modified":"2026-01-27T00:03:53","modified_gmt":"2026-01-27T00:03:53","slug":"crinetics-pharmaceuticals-to-report-fourth-quarter-and-full-year-2025-financial-results-on-february-26-2026","status":"publish","type":"post","link":"https:\/\/english.saigonbiz.com\/vn\/crinetics-pharmaceuticals-to-report-fourth-quarter-and-full-year-2025-financial-results-on-february-26-2026\/","title":{"rendered":"Crinetics Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026"},"content":{"rendered":"<div>\n<p align=\"justify\">SAN DIEGO, Jan.  26, 2026  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=SLsPuul54T_QzfMZ6MAi6Rs3nKR0R00gFmWPVul9ksNavKGqefv0U8uunkfLki-2akmxnLDJelIqzz7wcEOobV2afnKXxtnl4ZfLbLfVTTWkXlfruEZqcqbr0NRCoSGtGhuEcHOf-3EsWFrkf4xSwfqGtrQoMoJglJBda9OqVF1S1gbcGtxBi-44zxX5NSNqxWcUcCzsfxDA_OvI9uOQKA==\" rel=\"nofollow\" target=\"_blank\" title=\"\"><u>Crinetics Pharmaceuticals, Inc.<\/u><\/a> (Nasdaq: CRNX) today announced that it will report fourth quarter and full year 2025 financial results on Thursday, February 26, 2026 after the market closes. Company management will host a conference call at 4:30 p.m. ET to discuss financial results and provide a business update.<\/p>\n<p align=\"justify\"><strong>Conference Call &amp; Webcast<\/strong><\/p>\n<p align=\"justify\"><u>Thursday, February 26 at 4:30 p.m. ET<\/u><\/p>\n<table style=\"border-collapse: collapse; width:100%; border-collapse:collapse ;\">\n<tr>\n<td style=\"max-width:12%; width:12%; min-width:12%;;vertical-align: top ; \">Domestic:<\/td>\n<td style=\"max-width:1%; width:1%; min-width:1%;;vertical-align: top ; \">\u00a0<\/td>\n<td style=\"max-width:87%; width:87%; min-width:87%;;vertical-align: top ; \">1 833-470-1428<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top ; \">International:<\/td>\n<td style=\"vertical-align: top ; \">\u00a0<\/td>\n<td style=\"vertical-align: top ; \">1 646-844-6383<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top ; \">Access Code:<\/td>\n<td style=\"vertical-align: top ; \">\u00a0<\/td>\n<td style=\"vertical-align: top ; \">027322<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top ; \">\u00a0<\/td>\n<td style=\"vertical-align: top ; \">\u00a0<\/td>\n<td style=\"vertical-align: top ; \">\u00a0<\/td>\n<\/tr>\n<\/table>\n<p align=\"justify\"><strong>Webcast:<\/strong> Participants can use the dial-in numbers above OR access the live webcast via a direct link (<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=g1vsoywJMAkgm0qhpLlhc0xhorV88RCMx1NfGpjda6cjmv6-TPb9ot48Ee0FApyGAfOHgtnw5vRpRW3_iQMYKRCQp4Tdbw3ZG77-g5VHY1Q=\" rel=\"nofollow\" target=\"_blank\" title=\"HERE\">HERE<\/a>) or by visiting the <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=s-_a8-fO6YUwDY0Ag4Q9WsDOlGrkOcERQ4jPB7TTcwYKNtdxHTyfv6XOpeYXjtrnIaWLSXOFVYEgX1h2avDWQwEzUGgRUFaUpboEhr9da60=\" rel=\"nofollow\" target=\"_blank\" title=\"Events section\">Events section<\/a> of the Crinetics website. To ensure a timely connection, it is recommended that participants connect at least 15 minutes prior to the scheduled start of the call.<\/p>\n<p align=\"justify\">The webcast will be archived on the Investor Relations section of <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=8c2LmbX6jzt7SsW0sfICj1t19bod3e4U0HUVIWbwWfyjonsU-mnFZFLMMxnqOFUiIj4EL9VfrUMWlsepaEIMtkXaHPnUckH3jPe6X21Med0=\" rel=\"nofollow\" target=\"_blank\" title=\"www.crinetics.com\">www.crinetics.com<\/a>.<\/p>\n<p align=\"justify\"><strong>About Crinetics Pharmaceuticals <\/strong><br \/>Crinetics Pharmaceuticals is a global pharmaceutical company committed to transforming the treatment of endocrine diseases and endocrine-related tumors through science rooted in patient needs. Crinetics is focused on discovering, developing, and commercializing novel therapies, with a core expertise in targeting G-protein coupled receptors (GPCRs) with small molecules that have specifically tailored pharmacology and properties.<\/p>\n<p>Crinetics\u2019 lead product, PALSONIFY&#x2122; (paltusotine), is the first once-daily, oral treatment approved by the U.S. FDA for the treatment of adults with acromegaly who had an inadequate response to surgery and\/or for whom surgery is not an option. Paltusotine is also in clinical development for carcinoid syndrome associated with neuroendocrine tumors. Crinetics\u2019 deep pipeline of 10+ disclosed programs includes late-stage investigational candidate atumelnant, which is currently in development for congenital adrenal hyperplasia and ACTH-dependent Cushing\u2019s syndrome, and CRN09682, a nonpeptide drug conjugate candidate that is being developed to treat SST2 expressing neuroendocrine tumors and other SST2 expressing solid tumors. Additional discovery programs address a variety of endocrine conditions such as neuroendocrine tumors, Graves\u2019 disease (including Graves\u2019 hyperthyroidism and Graves\u2019 orbitopathy, or thyroid eye disease), polycystic kidney disease, hyperparathyroidism, diabetes, obesity, and GPCR-targeted oncology indications.<\/p>\n<p><strong>Investors:<\/strong><br \/>Gayathri Diwakar<br \/>Head of Investor Relations<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=K6b6iRuIDdOn-PnaTQi0ZaCIrEWbrXzKMmafDCnAeSPdgAGmrEojd1p1XnVExiFKd4CPcQNJmORMDdbyOpKOsrnddQ3oq4WWChi3ojyegUU=\" rel=\"nofollow\" target=\"_blank\" title=\"gdiwakar@crinetics.com\">gdiwakar@crinetics.com<\/a> <br \/>(858) 345-6340<\/p>\n<p><strong>Media:<\/strong> <br \/>Natalie Badillo<br \/>Head of Corporate Communications <br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=bp3L8Gtu1gCjAB-yT-QCzcEpAKOLv8GXYXgrQiVs1IpGnSf83K2_v1GnewHMMDc3ewffcXEhl3NNfJEzPVuYiijC-Qk62gECS5AEEvXa1Mo=\" rel=\"nofollow\" target=\"_blank\" title=\"nbadillo@crinetics.com\">nbadillo@crinetics.com<\/a> <br \/>(858) 345-6075<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/OWUzYWQ5OWQtMWU5YS00MWZjLTg4NzQtMTc1NmNmMmViMjViLTExMDEzODYtMjAyNi0wMS0yNi1lbg==\/tiny\/Crinetics-Pharmaceuticals-Inc-.png\" referrerpolicy=\"no-referrer-when-downgrade\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SAN DIEGO, Jan. 26, 2026 (GLOBE NEWSWIRE) &#8212; Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that it will report fourth quarter and full year 2025 financial results on Thursday, February 26, 2026 after the market closes. Company management will host a conference call at 4:30 p.m. ET to discuss financial results and provide a business [&#8230;]\n","protected":false},"author":1,"featured_media":76773,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-76772","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pr-newswire"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v21.6 (Yoast SEO v21.6) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Crinetics Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026 - Biz and Live in Saigon<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/english.saigonbiz.com\/vn\/crinetics-pharmaceuticals-to-report-fourth-quarter-and-full-year-2025-financial-results-on-february-26-2026\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Crinetics Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026\" \/>\n<meta property=\"og:description\" content=\"SAN DIEGO, Jan. 26, 2026 (GLOBE NEWSWIRE) &#8212; Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that it will report fourth quarter an\" \/>\n<meta property=\"og:url\" content=\"https:\/\/english.saigonbiz.com\/vn\/crinetics-pharmaceuticals-to-report-fourth-quarter-and-full-year-2025-financial-results-on-february-26-2026\/\" \/>\n<meta property=\"og:site_name\" content=\"Biz and Live in Saigon\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/SaigonbizGroup\" \/>\n<meta property=\"article:published_time\" content=\"2026-01-27T00:03:53+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/01\/Crinetics-Pharmaceuticals-Inc-1-1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1\" \/>\n\t<meta property=\"og:image:height\" content=\"1\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/crinetics-pharmaceuticals-to-report-fourth-quarter-and-full-year-2025-financial-results-on-february-26-2026\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/crinetics-pharmaceuticals-to-report-fourth-quarter-and-full-year-2025-financial-results-on-february-26-2026\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\"},\"headline\":\"Crinetics Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026\",\"datePublished\":\"2026-01-27T00:03:53+00:00\",\"dateModified\":\"2026-01-27T00:03:53+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/crinetics-pharmaceuticals-to-report-fourth-quarter-and-full-year-2025-financial-results-on-february-26-2026\/\"},\"wordCount\":360,\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"articleSection\":[\"Pr Newswire\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/crinetics-pharmaceuticals-to-report-fourth-quarter-and-full-year-2025-financial-results-on-february-26-2026\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/crinetics-pharmaceuticals-to-report-fourth-quarter-and-full-year-2025-financial-results-on-february-26-2026\/\",\"name\":\"Crinetics Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026 - Biz and Live in Saigon\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\"},\"datePublished\":\"2026-01-27T00:03:53+00:00\",\"dateModified\":\"2026-01-27T00:03:53+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/crinetics-pharmaceuticals-to-report-fourth-quarter-and-full-year-2025-financial-results-on-february-26-2026\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/english.saigonbiz.com\/vn\/crinetics-pharmaceuticals-to-report-fourth-quarter-and-full-year-2025-financial-results-on-february-26-2026\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/crinetics-pharmaceuticals-to-report-fourth-quarter-and-full-year-2025-financial-results-on-february-26-2026\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/english.saigonbiz.com\/vn\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Crinetics Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"name\":\"Biz and Live in Saigon\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\",\"name\":\"SaigonBiz Media\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"width\":512,\"height\":512,\"caption\":\"SaigonBiz Media\"},\"image\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/SaigonbizGroup\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"caption\":\"admin\"},\"sameAs\":[\"https:\/\/english.saigonbiz.com\/vn\"],\"url\":\"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Crinetics Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026 - Biz and Live in Saigon","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/english.saigonbiz.com\/vn\/crinetics-pharmaceuticals-to-report-fourth-quarter-and-full-year-2025-financial-results-on-february-26-2026\/","og_locale":"en_US","og_type":"article","og_title":"Crinetics Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026","og_description":"SAN DIEGO, Jan. 26, 2026 (GLOBE NEWSWIRE) &#8212; Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that it will report fourth quarter an","og_url":"https:\/\/english.saigonbiz.com\/vn\/crinetics-pharmaceuticals-to-report-fourth-quarter-and-full-year-2025-financial-results-on-february-26-2026\/","og_site_name":"Biz and Live in Saigon","article_publisher":"https:\/\/www.facebook.com\/SaigonbizGroup","article_published_time":"2026-01-27T00:03:53+00:00","og_image":[{"width":1,"height":1,"url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/01\/Crinetics-Pharmaceuticals-Inc-1-1.png","type":"image\/png"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/english.saigonbiz.com\/vn\/crinetics-pharmaceuticals-to-report-fourth-quarter-and-full-year-2025-financial-results-on-february-26-2026\/#article","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/crinetics-pharmaceuticals-to-report-fourth-quarter-and-full-year-2025-financial-results-on-february-26-2026\/"},"author":{"name":"admin","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6"},"headline":"Crinetics Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026","datePublished":"2026-01-27T00:03:53+00:00","dateModified":"2026-01-27T00:03:53+00:00","mainEntityOfPage":{"@id":"https:\/\/english.saigonbiz.com\/vn\/crinetics-pharmaceuticals-to-report-fourth-quarter-and-full-year-2025-financial-results-on-february-26-2026\/"},"wordCount":360,"publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"articleSection":["Pr Newswire"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/english.saigonbiz.com\/vn\/crinetics-pharmaceuticals-to-report-fourth-quarter-and-full-year-2025-financial-results-on-february-26-2026\/","url":"https:\/\/english.saigonbiz.com\/vn\/crinetics-pharmaceuticals-to-report-fourth-quarter-and-full-year-2025-financial-results-on-february-26-2026\/","name":"Crinetics Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026 - Biz and Live in Saigon","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#website"},"datePublished":"2026-01-27T00:03:53+00:00","dateModified":"2026-01-27T00:03:53+00:00","breadcrumb":{"@id":"https:\/\/english.saigonbiz.com\/vn\/crinetics-pharmaceuticals-to-report-fourth-quarter-and-full-year-2025-financial-results-on-february-26-2026\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/english.saigonbiz.com\/vn\/crinetics-pharmaceuticals-to-report-fourth-quarter-and-full-year-2025-financial-results-on-february-26-2026\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/english.saigonbiz.com\/vn\/crinetics-pharmaceuticals-to-report-fourth-quarter-and-full-year-2025-financial-results-on-february-26-2026\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/english.saigonbiz.com\/vn\/"},{"@type":"ListItem","position":2,"name":"Crinetics Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026"}]},{"@type":"WebSite","@id":"https:\/\/english.saigonbiz.com\/vn\/#website","url":"https:\/\/english.saigonbiz.com\/vn\/","name":"Biz and Live in Saigon","description":"","publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/english.saigonbiz.com\/vn\/#organization","name":"SaigonBiz Media","url":"https:\/\/english.saigonbiz.com\/vn\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","width":512,"height":512,"caption":"SaigonBiz Media"},"image":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/SaigonbizGroup"]},{"@type":"Person","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6","name":"admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","caption":"admin"},"sameAs":["https:\/\/english.saigonbiz.com\/vn"],"url":"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/76772","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/comments?post=76772"}],"version-history":[{"count":0,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/76772\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media\/76773"}],"wp:attachment":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media?parent=76772"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/categories?post=76772"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/tags?post=76772"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}